420 with CNW Archives - Page 38 of 320

FridayDec 06, 2024 4:20 pm

420 with CNW — Study: Utah’s Medical Cannabis Legalization Lowered Opioid Use by Patients with Chronic Pain

A recent study examining the use of prescribed opioids in Utah after medical cannabis legalization in the state highlights a significant reduction in opioid consumption among patients managing chronic pain. The findings also show a substantial decline in opioid prescription-related deaths since Utah authorized medical marijuana in 2018. The study highlights the increasing use of cannabis for pain relief and its potential to lessen opiate dependence. It concludes that cannabis could be a promising option as healthcare providers explore safer methods for managing pain, especially for individuals with chronic pain conditions. The Utah study analyzed 186 chronic pain patients, using…

ThursdayDec 05, 2024 4:20 pm

420 with CNW — Federal Court Upholds Ban on Cannabis Advertising in Mississippi

Mississippi’s medical cannabis businesses are prohibited from advertising on billboards or any other platforms due to marijuana’s federal status as an illegal substance, according to a recent decision by an appeals court. The owner of Tru Source Medical Marijuana, a medical cannabis store operating in Olive Branch, Mississippi, contested this restriction. He claimed that since state law allows the sale of marijuana, the First Amendment should protect medical cannabis businesses’ advertising rights. However, on Friday, a three-judge bench from the 5th Circuit Court of Appeals ruled against the dispensary owner. The court referred to the federal Controlled Substances Act (CSA),…

WednesdayDec 04, 2024 4:20 pm

420 with CNW — FDA OKs Study Exploring Marijuana Use for Treating PTSD in Veterans

This week, the U.S. Food and Drug Administration (FDA) granted long-awaited approval for a clinical trial exploring whether cannabis can help manage veterans’ post-traumatic stress disorder (PTSD). The trial, which is being led by the Multidisciplinary Association for Psychedelic Studies (MAPS), has faced delays since 2021 due to various objections raised by the FDA. Concerns included the potential risks associated with smoking high-potency marijuana and the study’s dosing method, which allows participants to regulate their intake within set daily limits. MAPS said on Wednesday that the FDA had lifted its objections, allowing the study to move forward. Notably, the agency…

TuesdayDec 03, 2024 4:20 pm

420 with CNW — Study Finds That Adolescents Suffer More Severe Psychosis Symptoms if They Use Marijuana

A recent study by researchers from St. Louis’ Washington University has found that teenagers who use marijuana experience more signs of psychosis spectrum and higher levels of distress due to the symptoms. This suggests that both self-medication and shared vulnerability play a role in linking marijuana use to an increased risk of psychosis. Previous research indicates that teenagers who use marijuana have a two to four times higher risk of developing psychosis than their non-user counterparts. Marijuana usage that starts in youth is frequently linked to more intense symptoms, a higher chance of relapse, and an earlier beginning of psychotic…

MondayDec 02, 2024 4:20 pm

420 with CNW — Nebraska AG Pledges That Ongoing Investigations Won’t Impact Cannabis Measure’s Certification

Mike Hilgers, Nebraska’s Attorney General, assured the public on Tuesday that his office’s current investigations into two medical marijuana ballot measures will not affect his decision to certify the election results. Speaking at a press conference on an unrelated lawsuit, Hilgers stated that the election certification process would proceed independently of the marijuana-related legal disputes or the timing of any court ruling. Hilgers is one of five state constitutional officials who will convene on December 2 to decide if, or not to certify the election results from November 5. This includes the resounding support of two initiatives from voters: Measure…

WednesdayNov 27, 2024 4:20 pm

420 with CNW — Key Lessons from the Marijuana Liberalization Journey of the US

The journey toward cannabis legalization in the United States has been significant, with nearly half of the states now allowing its recreational use. However, the topic remains contentious and divisive, frequently leveraged by politicians. Some invoke fears about potential harm to oppose legalization, while others emphasize benefits such as increased revenue and reduced violent crime to advocate for it. Scientific research on marijuana-related harms is relatively comprehensive. Regular consumption of high-potency marijuana, especially when initiated at a young age, is linked to mental health issues, including schizophrenia. It may also lead to cognitive difficulties, reduced academic performance, and an elevated…

TuesdayNov 26, 2024 4:20 pm

420 with CNW — Australian Parliament to Vote on Cannabis Legalization This November

Australian legislators are preparing to vote on legislation that could pave the way for adult-use cannabis legalization across the nation. Senator David Shoebridge of the Greens Party, who has spearheaded the effort, announced on social media that the proposed bill is scheduled for a vote in Parliament on November 27. The legislation seeks to establish a regulated cannabis market, complete with taxation and licensing. Central to the plan is the creation of the Cannabis Australia National Agency (CANA), which would oversee licensing and regulations and maintain a comprehensive register of cannabis strains. The bill also explicitly permits home growth for…

MondayNov 25, 2024 4:20 pm

420 with CNW — New Report Says Millennials Lead Other Generations in Buying Marijuana Pre-Rolls

Millennials, the largest generational group in the U.S., are shaping spending habits across industries, including marijuana. According to a recent survey, this age group, ranging from 28 to 43 years old, has become a dominant force in the joint market, making up 45% of the $3 billion industry. Harrison Bard, the CEO and co-founder of Custom Cones U.S., noted that millennials occupy a unique position. “They have more disposable income and greater freedom compared to younger generations,” Bard explained, adding that the generation grew up during a time when cannabis was becoming more normalized. The study, conducted by Custom Cones…

FridayNov 22, 2024 4:20 pm

420 with CNW — New Study Explores the Health Conditions for Which Individuals Use Medical Cannabis

A recently released analysis of numerous medical cannabis patients within the United States reveals that PTSD, pain, and anxiety are the most common conditions qualifying individuals for medical marijuana programs. The study indicates that 58.6% of patients reported managing more than one medical condition with cannabis. Among those dealing with multiple conditions, chronic pain and anxiety were the most frequently cited, followed by issues such as PTSD, insomnia, and muscle spasms. The research was conducted by Leafwell, a specialized platform that facilitates access to medical cannabis cards, in collaboration with San Diego University’s Center for Marijuana Research and Duke University…

ThursdayNov 21, 2024 4:20 pm

420 with CNW — Trump’s Pick for AG Triggers Hope Within the Marijuana Community

Donald Trump’s choice of Florida Representative Matt Gaetz as the next Attorney General has sparked controversy across party lines. Gaetz’s resignation from his congressional seat followed shortly after the announcement, just days before the House Ethics Committee was expected to address an ongoing investigation into allegations against him. These accusations, which Gaetz has denied, include claims of sexual misconduct and illicit drug use. The nomination raises uncertainty about Senate approval, but it has already ignited significant interest within the cannabis industry. According to David Culver, senior vice president of public affairs at the U.S. Marijuana Council, Gaetz is among the…